| Telciane Vesa, MD | |
|
1860 Chadwick Dr Ste 351, Jackson, MS 39204-3472 | |
| (601) 376-1288 | |
| Not Available |
| Full Name | Telciane Vesa |
|---|---|
| Gender | Female |
| Speciality | Gastroenterology |
| Experience | 22 Years |
| Location | 1860 Chadwick Dr Ste 351, Jackson, Mississippi |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295932168 | NPI | - | NPPES |
| 1295932168 | Medicaid | MO | |
| 08278258 | Medicaid | MS |
| Facility Name | Location | Facility Type |
|---|---|---|
| Forrest General Hospital | Hattiesburg, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hattiesburg Clinic, Pa | 5193706794 | 489 |
News Archive
Haemacure Corporation announces that it has today obtained a first extension until March 22, 2010 of the delay within which to make a proposal pursuant to the notice of intention to make a proposal to its creditors it filed on January 8, 2010 under the Bankruptcy and Insolvency Act (Canada). This extension is intended to allow Haemacure to complete a call for tenders for the sale of its assets, close a sale transaction with the successful tenderer, seek the required approvals for the transaction and proposal to creditors, and execute the proposal.
In his latest Kaiser Health News column, Austin Frakt writes: "I agree with those who think the Patient Protection and Affordable Care Act doesn't do enough soon enough to control the rate of increase in health insurance premiums.
In a recent study published in Tobacco Control, researchers at the University of Ottawa Heart Institute have demonstrated the cost-effectiveness of the Ottawa Model for Smoking Cessation (OMSC), an intervention that includes in-hospital counseling, pharmacotherapy and post-hospital follow-up, compared to usual care among smokers hospitalized with acute myocardial infarction, unstable angina, heart failure, and chronic obstructive pulmonary disease.
QHR Technologies Inc. today announced that the Company has signed an Asset Purchase Agreement ("APA") to acquire the assets of EMIS Inc. a 100% subsidiary of Egton Medical Information Systems Limited based in Leeds, UK and part of EMIS Group plc.
TargeGen, Inc. today announced that the Company has successfully completed a 59 patient, multicenter clinical trial of TG101348, an oral, potent, and highly selective inhibitor of JAK2 in patients with myelofibrosis.
› Verified 5 days ago
| Entity Name | Hattiesburg Clinic Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740213446 PECOS PAC ID: 5193706794 Enrollment ID: O20040528000685 |
News Archive
Haemacure Corporation announces that it has today obtained a first extension until March 22, 2010 of the delay within which to make a proposal pursuant to the notice of intention to make a proposal to its creditors it filed on January 8, 2010 under the Bankruptcy and Insolvency Act (Canada). This extension is intended to allow Haemacure to complete a call for tenders for the sale of its assets, close a sale transaction with the successful tenderer, seek the required approvals for the transaction and proposal to creditors, and execute the proposal.
In his latest Kaiser Health News column, Austin Frakt writes: "I agree with those who think the Patient Protection and Affordable Care Act doesn't do enough soon enough to control the rate of increase in health insurance premiums.
In a recent study published in Tobacco Control, researchers at the University of Ottawa Heart Institute have demonstrated the cost-effectiveness of the Ottawa Model for Smoking Cessation (OMSC), an intervention that includes in-hospital counseling, pharmacotherapy and post-hospital follow-up, compared to usual care among smokers hospitalized with acute myocardial infarction, unstable angina, heart failure, and chronic obstructive pulmonary disease.
QHR Technologies Inc. today announced that the Company has signed an Asset Purchase Agreement ("APA") to acquire the assets of EMIS Inc. a 100% subsidiary of Egton Medical Information Systems Limited based in Leeds, UK and part of EMIS Group plc.
TargeGen, Inc. today announced that the Company has successfully completed a 59 patient, multicenter clinical trial of TG101348, an oral, potent, and highly selective inhibitor of JAK2 in patients with myelofibrosis.
› Verified 5 days ago
| Entity Name | State Of Mississippi - University Of Mississippi Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154317527 PECOS PAC ID: 1850293036 Enrollment ID: O20090414000575 |
News Archive
Haemacure Corporation announces that it has today obtained a first extension until March 22, 2010 of the delay within which to make a proposal pursuant to the notice of intention to make a proposal to its creditors it filed on January 8, 2010 under the Bankruptcy and Insolvency Act (Canada). This extension is intended to allow Haemacure to complete a call for tenders for the sale of its assets, close a sale transaction with the successful tenderer, seek the required approvals for the transaction and proposal to creditors, and execute the proposal.
In his latest Kaiser Health News column, Austin Frakt writes: "I agree with those who think the Patient Protection and Affordable Care Act doesn't do enough soon enough to control the rate of increase in health insurance premiums.
In a recent study published in Tobacco Control, researchers at the University of Ottawa Heart Institute have demonstrated the cost-effectiveness of the Ottawa Model for Smoking Cessation (OMSC), an intervention that includes in-hospital counseling, pharmacotherapy and post-hospital follow-up, compared to usual care among smokers hospitalized with acute myocardial infarction, unstable angina, heart failure, and chronic obstructive pulmonary disease.
QHR Technologies Inc. today announced that the Company has signed an Asset Purchase Agreement ("APA") to acquire the assets of EMIS Inc. a 100% subsidiary of Egton Medical Information Systems Limited based in Leeds, UK and part of EMIS Group plc.
TargeGen, Inc. today announced that the Company has successfully completed a 59 patient, multicenter clinical trial of TG101348, an oral, potent, and highly selective inhibitor of JAK2 in patients with myelofibrosis.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Telciane Vesa, MD Po Box 321359, Flowood, MS 39232-1359 Ph: (601) 933-6593 | Telciane Vesa, MD 1860 Chadwick Dr Ste 351, Jackson, MS 39204-3472 Ph: (601) 376-1288 |
News Archive
Haemacure Corporation announces that it has today obtained a first extension until March 22, 2010 of the delay within which to make a proposal pursuant to the notice of intention to make a proposal to its creditors it filed on January 8, 2010 under the Bankruptcy and Insolvency Act (Canada). This extension is intended to allow Haemacure to complete a call for tenders for the sale of its assets, close a sale transaction with the successful tenderer, seek the required approvals for the transaction and proposal to creditors, and execute the proposal.
In his latest Kaiser Health News column, Austin Frakt writes: "I agree with those who think the Patient Protection and Affordable Care Act doesn't do enough soon enough to control the rate of increase in health insurance premiums.
In a recent study published in Tobacco Control, researchers at the University of Ottawa Heart Institute have demonstrated the cost-effectiveness of the Ottawa Model for Smoking Cessation (OMSC), an intervention that includes in-hospital counseling, pharmacotherapy and post-hospital follow-up, compared to usual care among smokers hospitalized with acute myocardial infarction, unstable angina, heart failure, and chronic obstructive pulmonary disease.
QHR Technologies Inc. today announced that the Company has signed an Asset Purchase Agreement ("APA") to acquire the assets of EMIS Inc. a 100% subsidiary of Egton Medical Information Systems Limited based in Leeds, UK and part of EMIS Group plc.
TargeGen, Inc. today announced that the Company has successfully completed a 59 patient, multicenter clinical trial of TG101348, an oral, potent, and highly selective inhibitor of JAK2 in patients with myelofibrosis.
› Verified 5 days ago
Graves Crawley Stubblefield Jr., M.D. Gastroenterology Medicare: Medicare Enrolled Practice Location: 406 Briarwood Dr, Jackson, MS 39206 Phone: 601-991-1933 Fax: 601-978-3844 | |
Dr. Rebecca Chick Pace, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1200 N State St, Suite 500, Jackson, MS 39202 Phone: 601-352-2273 Fax: 601-714-3415 | |
Jewelian Akbar Baig, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 971 Lakeland Dr Ste 356, Jackson, MS 39216 Phone: 601-200-4644 Fax: 601-200-4645 | |
Jo P Deal, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 766 Lakeland Dr # A, Jackson, MS 39216 Phone: 601-368-3440 Fax: 601-368-3441 | |
Caryl P. Sumrall, FNP Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 2500 North State Street, Department Of Medicine/division Of General Internal Med, Jackson, MS 39216 Phone: 601-984-5660 | |
Meghan Alford Luter, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-5532 | |
Tammy H Young, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1227 N State St, Ste 101, Jackson, MS 39202 Phone: 601-355-2485 Fax: 601-353-1463 |